Association between serum vitamin D and metabolic syndrome in middle-aged and older adults and role of supplementation therapy with vitamin D.
Ann Ist Super Sanita. 2017 Jan-Mar;53(1):54-59. doi: 10.4415/ANN_17_01_11.
6 months of Vitamin D
Initial | Loading dose1 | Loading Dose 2 | Maintenance dose for remainder of 6 months |
< 10 ng | 50,000 IU weekly 4 weeks | 25,000 IU weekly 4 weeks | 25,000 every two weeks |
10-20 ng | - | 25,000 IU weekly 4 weeks | 25,000 every two weeks |
20-30 ng | - | 25,000 every 2 weeks for 8 weeks | 25,000 once every 4 weeks |
Note: some other groups have all loading dosing completed in 1 week, or even one day
Study did not test vitamin D levels at the end of the 6 months, but probably those getting > 30ng of Vitamin D would have had much more than a 3 cm reduction in waist size
See also VitaminDWiki
- Vitamins To Speed Up Metabolism And Aid Weight Loss – May 2011
- Overview Metabolic Syndrome and vitamin D
- Weight loss and Vitamin D, Calcium, and Magnesium
- Dieters lost 5 more pounds if achieved more than 32 ng of vitamin D – RCT March 2014
- Less weight gain if add Vitamin D, even if have a high fat diet (in rats) – RCT Dec 2017
- Obese are 30 percent more likely to have poor Vitamin D Receptor – Aug 2017
There are many ways to get-around the Vitamin D Receptor problem
Overview Loading of vitamin D contains the following
Loading dose:Vitamin D loading dose (stoss therapy) proven to improve health overview
If a person is or is suspected to be, very vitamin D deficient a loading dose should be given
- Loading = restore = quick replacement by 1 or more doses
- Loading doses range in total size from 100,000 IU to 1,000,000 IU of Vitamin D3
- = 2.5 to 25 milligrams
- The size of the loading dose is a function of body weight - see below
- Unfortunately, some doctors persist in using Vitamin D2 instead of D3
- Loading may be done as quickly as a single day (Stoss), to as slowly as 3 months.
- It appears that spreading the loading dose over 4+ days is slightly better if speed is not essential
- Loading is typically oral, but can be Injection (I.M,) and Topical
- Loading dose is ~3X faster if done topically or swished inside of the mouth
- Skips the slow process of stomach and intestine, and might even skip liver and Kidney as well
- The loading dose persists in the body for 1 - 3 months
- The loading dose should be followed up with on-going maintenance dosing
- Unfortunately, many doctors fail to follow-up with the maintenance dosing.
- About 1 in 300 people have some form of a mild allergic reaction to vitamin D supplements, including loading doses
- it appears prudent to test with a small amount of vitamin D before giving a loading dose
- The causes of a mild allergic reaction appear to be: (in order of occurrence)
- 1) lack of magnesium - which can be easily added
- 2) allergy to capsule contents - oil, additives (powder does not appear to cause any reaction)
- 3) allergy to the tiny amount of D3 itself (allergy to wool) ( alternate: D3 made from plants )
- 4) allergy of the gut to Vitamin D - alternative = topical
Items in both categories Obesity and Metabolic Syndrome are listed here:
- Metabolic Syndromes fought by Vitamin D in 6 ways – Oct 2023
- UV reduces cardiovascular and metabolic problems– Vitamin D plus Nitric oxide – Sept 2023
- Magnesium in Obesity, Metabolic Syndrome, and Type 2 Diabetes - Jan 2021
- The Role of Magnesium in the Pathogenesis of Metabolic Disorders – April 2022
- Vitamin D is linked to metabolic syndrome and obesity – Aug 2019
- Metabolic Syndrome associated with low vitamin D in abdominal obese women – Jan 2019
- Obesity and Vitamin D – Review July 2018
- How Omega-3 fights metabolic syndrome and weight – Feb 2018
- BMI reduced by Vitamin D (not much reduction – only got VitD to 26 ng) – RCT Feb 2018
- Waist size reduced 3 cm by Vitamin D in those with Metabolic Syndrome – Jan 2017
- Metabolic Syndrome with and without obesity has low vitamin D - Oct 2016
- Obese youths 2X less likely to develop Metabolic Syndrome if take Omega-3 – RCT April 2016
- Hypothesis: Energy metabolism is associated with Vitamin D – April 2015
- Diabetic hypertension reduced with Vitamin D and Calcium – RCT March 2015
- UV (perhaps Nitric Oxide) better than vitamin D at preventing obesity in rats on a high-fat diet – Nov 2014
- Hypothesis- Metabolic disease is due to Tissue Renin-Angiotensin Systems – Feb 2014
- UV better than vitamin D in reducing metabolic syndrome in mice – Thesis Aug 2013
- Metabolic Syndrome 10% less likely for every 4 ng increase in Vitamin D – Jan 2013
- 5700 IU vitamin D improved various growth factors in overweight people – Oct 2012
- 3X more abdominal obesity among Korean children having low vitamin D – July 2012
- Overview Metabolic Syndrome and vitamin D
Images from web
 Download the PDF from VitaminDWiki
Verrusio W1, Andreozzi P1, Renzi A2, Musumeci M1, Gueli N1, Cacciafesta M1.
1 Dipartimento di Scienze Cardiovascolari, Respiratorie, Nefrologiche, Anestesiologiche e Geriatriche, Sapienza Università di Roma, Rome, Italy.
2 Dipartimento di Psicologia Dinamica e Clinica, Sapienza Università di Roma, Rome, Italy.
OBJECTIVES: To evaluate i) the correlation between vitamin D (vit. D) serum concentrations and metabolic syndrome (MetS); ii) the efficacy of 6 months supplementation therapy with vit. D.
METHOD: 200 patients were enrolled. Blood analyses and anthropometric measurements were carried out. Patients with hypovitaminosis D received an oral supplement therapy.
RESULTS:
81% of the sample shows vit. D levels < 30 ng/mL. Rate of MetS was significantly higher in vit. D deficiency group than in vit D insufficiency (p = 0.009) and sufficiency (p = 0.002) groups. Vit. D shows a significant negative correlation with both waist circumference (WC) (ρ - 0.202 p = 0.004) and glycaemia values (FBG) (ρ -0.185 p = 0.009). After the supplementation therapy in a group of 60 subjects a significant increase in vit. D levels (p = 0.001) and a significant reduction in WC values (p = 0.001) were observed.
CONCLUSIONS:
MetS, WC and FBG appeared to be associated vit. D status and it is well-known that central obesity, with the inflammatory alterations thereto correlated that determine insulin resistance, can be considered the "primum movens" for the development of MetS.
PMID: 28361806 DOI: 10.4415/ANN_17_01_11
8422 visitors, last modified 02 Jul, 2020, |
ID | Name | Uploaded | Size | Downloads | |
---|---|---|---|---|---|
9132 | MetS 4 cm.jpg | admin 05 Jan, 2018 | 14.03 Kb | 1330 | |
9131 | MetS Jan 2017.pdf | admin 05 Jan, 2018 | 89.04 Kb | 1054 |